Uipath, INC Form 4 insider transactions
NYSE
PATH
Uipath, INCUiPath CEO and Chairman Daniel Dines has filed a Form 4 indicating a pre-planned sale of 45,000 shares of Class A Common Stock on July 1, 2025, under a Rule 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath's Chief Accounting Officer, Hitesh Ramani, reported the disposition of 26,057 shares of Class A Common Stock on July 1, 2025, to cover tax obligations from RSU vesting.
NYSE
PATH
Uipath, INCUiPath's GC & Chief Legal Officer, Brad Brubaker, disposed of 34,228 Class A Common Stock shares at $12.8 per share to cover tax obligations related to RSU vesting.
NYSE
PATH
Uipath, INCUiPath's Chief Operating and Financial Officer, Ashim Gupta, reported the disposition of 71,009 shares of Class A Common Stock on July 1, 2025, to cover tax obligations related to RSU vesting.
NYSE
PATH
Uipath, INCUiPath, Inc. Director Karenann K Terrell was granted 16,064 Restricted Stock Units (RSUs) as part of the company's non-employee director compensation policy.
NYSE
PATH
Uipath, INCUiPath, Inc. Director June Yang was granted 16,064 Restricted Stock Units (RSUs) as part of the company's non-employee director compensation policy, increasing her direct beneficial ownership to 59,171 shares.
NYSE
PATH
Uipath, INCUiPath, Inc. Director Sivaramakichenane Somasegar was granted 16,064 Class A Common Stock Restricted Stock Units (RSUs) as part of the company's non-employee director compensation policy.
NYSE
PATH
Uipath, INCUiPath, Inc. Director Daniel D. Springer was granted 16,064 Restricted Stock Units (RSUs) as part of the company's non-employee director compensation policy.
NYSE
PATH
Uipath, INCUiPath, Inc. Director Michael Lawrence Gordon was granted 16,064 Class A Common Stock Restricted Stock Units as part of the company's non-employee director compensation policy.
NYSE
PATH
Uipath, INCUiPath, Inc. Director Rich Wong was granted 16,064 Restricted Stock Units (RSUs) as part of the company's non-employee director compensation policy, increasing his direct beneficial ownership.
NYSE
PATH
Uipath, INCUiPath Director Philippe Botteri was granted 16,064 Restricted Stock Units as part of the company's non-employee director compensation policy.
NYSE
PATH
Uipath, INCUiPath CEO and Chairman Daniel Dines has filed a Form 4 indicating a planned sale of 45,000 shares of Class A Common Stock on June 30, 2025, under a Rule 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath, Inc. CEO and Chairman Daniel Dines sold 45,000 shares of Class A Common Stock for approximately $575,000 through a pre-arranged Rule 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath, Inc. CEO and Chairman Daniel Dines reported the sale of 45,000 shares of Class A Common Stock on June 26, 2025, executed under a Rule 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath CEO and Chairman Daniel Dines sold 45,000 shares of Class A Common Stock for approximately $12.55 per share on June 25, 2025, as part of a pre-arranged Rule 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath, Inc. CEO and Chairman Daniel Dines reported the sale of 45,000 shares of Class A Common Stock at an average price of $12.4876 per share, executed under a Rule 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath CEO and Chairman Daniel Dines reported the sale of 45,000 shares of Class A Common Stock on June 23, 2025, through a pre-arranged 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath, Inc. CEO and Chairman Daniel Dines reported the sale of 45,000 shares of Class A Common Stock on June 20, 2025, executed under a pre-arranged Rule 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath, Inc. CEO and Chairman Daniel Dines reported the sale of 45,000 shares of Class A Common Stock on June 18, 2025, executed under a Rule 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath, Inc. CEO and Chairman Daniel Dines reported the sale of 45,000 shares of Class A Common Stock on June 17, 2025, executed under a pre-arranged Rule 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath, Inc. CEO and Chairman Daniel Dines reported the sale of 90,000 Class A Common Stock shares through a Rule 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath, Inc. CEO and Chairman Daniel Dines executed the sale of 90,000 shares of Class A Common Stock over two days in June 2025, totaling approximately $1.16 million, as part of a pre-established Rule 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath, Inc. CEO and Chairman Daniel Dines reported the sale of 45,000 shares of Class A Common Stock for approximately $593,491 under a Rule 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath, Inc. CEO and Chairman Daniel Dines reported the sale of 45,000 shares of Class A Common Stock for approximately $13.08 per share, executed under a Rule 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath, Inc. CEO and Chairman Daniel Dines reported the sale of 45,000 shares of Class A Common Stock for approximately $589,779, executed under a Rule 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath, Inc. CEO and Chairman Daniel Dines has sold 45,000 shares of Class A Common Stock for approximately $592,492 under a Rule 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath CEO and Chairman Daniel Dines reported the sale of 45,000 shares of Class A Common Stock on June 4, 2025, executed under a Rule 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath, Inc. CEO and Chairman Daniel Dines reported the sale of 45,000 shares of Class A Common Stock on June 3, 2025, executed under a Rule 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath CEO and Chairman Daniel Dines reported the sale of 45,000 shares of Class A Common Stock for approximately $13.31 per share, executed under a Rule 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath's CEO and Chairman, Daniel Dines, sold 45,000 shares of Class A Common Stock at an average price of $13.176 per share on May 14, 2025, under a pre-arranged 10b5-1 trading plan.